EGFR Inhibitors, MHC Expression and Immune Responses : Can EGFR Inhibitors Be Used as Immune Response Modifiers?

OncoImmunology - United States
doi 10.4161/onci.1.1.18073
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

597 EGFR Monoclonal Antibodies and EGFR Tyrosine Kinase Inhibitors Have Distinct Effects on the Keratinocyte Innate Immune Response

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2015English

Tumors Resistant to EGFR Inhibitors Can Arise via Different Mechanisms

Cancer Discovery
Oncology
2016English

Integration of EGFR Inhibitors With Radiochemotherapy

Nature Reviews Cancer
Cancer ResearchOncology
2006English

Hitting the Target: Measuring EGFR Response to Tyrosine Kinase Inhibitors

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2005English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

EGFR Inhibitors in Treatment of Lung Adenocarcinoma

Research in Oncology
2014English

Immune Response Modifiers ? Mode of Action

Experimental Dermatology
BiochemistryDermatologyMolecular Biology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy